Abstract—
Isatin (indol-2,3-dione) is an endogenous indole found in the brain, peripheral tissues and biological body fluids of humans and animals. Its wide spectrum of biological activity is realized via interaction with numerous isatin-binding proteins; these include proteins playing an important role in the development of neurodegenerative pathology. In the context of the neuroprotective effect, the effect of isatin is comparable to the effects of deprenyl, a pharmacological agent used for treatment of Parkinson’s disease. In this study, the effects of the course of deprenyl (1 mg/kg) and isatin (20 mg/kg) administration for 21 days on the profile of the isatin-binding proteins of the liver of mice have been investigated. Proteomic profiling of liver isatin-binding proteins of control mice by means of 5-aminocaproylisatin as an affinity ligand resulted in identification of 105 proteins. Treatment of animals with a low dose of isatin slightly decreased (up to 91), while injections of deprenyl slightly increased (up to 120) the total number of isatin-binding proteins. 75 proteins were common for all three groups; they represented from 62.5% (in deprenyl treated mice) and 71% (in control mice), to 82% (isatin treated mice) of the total number of identified liver isatin-binding proteins. The proteomic analysis of the isatin-binding proteins of mice treated with isatin (20 mg/kg) or deprenyl (1 mg/kg) for 21 days revealed a representative group of proteins (n = 30) that were sensitive to the administration of these compounds. Taking into consideration the previously obtained results, it is reasonable to suggest that the change in the profile of isatin-binding proteins may be attributed to accumulation of isatin and deprenyl in the liver and interaction with target proteins prevents their subsequent binding to the affinity sorbent. In this context, the identified isatin-binding liver proteins of control animals that do not bind to the affinity sorbent (immobilized isatin analogue) after treatment of animals with either deprenyl or isatin appear to be specific targets directly interacting with isatin in vivo.
Similar content being viewed by others
REFERENCES
Medvedev, A., Buneeva, O., Gnedenko, O., Ershov, P., and Ivanov, A., Biofactors, 2018, vol. 44, no. 2, pp. 95–108.
Medvedev, A., Buneeva, O., and Glover, V., Biologics, 2007, vol. 1, no. 2, pp. 151–162.
Medvedev, A., Igosheva, N., Crumeyrolle-Arias, M., and Glover, V., Stress, 2005, vol. 8, no. 3, pp. 175–183.
Medvedev, A.E., Clow, A., Sandler, M., and Glover, V., Biochem. Pharmacol., 1996, vol. 52, pp. 385–391.
Crumeyrolle-Arias, M., Buneeva, O., Zgoda, V., Kopylov, A., Cardona, A., Tournaire, M.-C., Pozdnev, V., Glover, V., and Medvedev, A., J. Neurosci. Res., 2009, vol. 87, pp. 2763–2772.
Buneeva, O., Gnedenko, O., Zgoda, V., Kopylov, A., Glover, V., Ivanov, A., Medvedev, A., and Archakov, A., Proteomics, 2010, vol. 10, pp. 23–37.
Buneeva, O.A, Kopylov, A.T., Tikhonova, O.V., Zgoda, V.G., Medvedev, A.E., and Archakov, A.I., Biochemistry (Moscow), 2012, vol. 77, p. 1584–1599.
Szökö, É., Tábi, T., Riederer, P., Vécsei, L., and Magyar, K., J. Neural Transm. (Vienna), 2018 [Epub ahead of print] doi 10.1007/s00702-018-1853-9
Youdim, M., Edmondson, D., and Tipton, K., Nat. Rev. Neurosci., 2006, vol. 7, pp. 295–308.
Medvedev, A.E., Buneeva, O.A, Kopylov, A.T., Tikhonova, O.V., Medvedeva, M.V., Nerobkova, L.N., Kapitsa, I.G., and Zgoda, V.G., Biochemistry (Moscow), 2017, vol. 82, pp. 470–480.
Kragten, E., Lalande, I., Zimmermann, K., Roggo, S., Schindler, P., Muller, D., van Oostrum, J., Wald-meier, P., and Furst, P., J. Biol. Chem., 1998, vol. 273, pp. 5821–5828.
Tatton, W., Chalmers-Redman, R., and Tatton, N., J. Neural Transm. (Vienna), 2003, vol. 110, pp. 509–515.
Berry, M.D. and Boulton, A.A., Neurotoxicol. Teratol., 2002, vol. 24, pp. 667–673.
Medvedev, A., Buneeva, O., Gnedenko, O., Fedchenko, V., Medvedeva, M., Ivanov, Y., Glover, V., and Sandler, M., J. Neural Transm., 2006, suppl. 71, pp. 97–103.
Tristan, C., Shahania, N., Sedlaka, T., and Sawa, A., Cell Signal., 2011, vol. 23, no. 2, pp. 317–323.
Buneeva, O.A., Gnedenko. O.V., Medvedeva, M.V., Ivanov, Yu.D., Glover, V., and Medvedev, A.E., Biomed. Khim., 2006, vol. 52, no. 4, pp. 413–418.
Buneeva, O.A., Kopylov, A.T., Zgoda, V.G., and Medvedev, A.E., Biomedical Chemistry: Research and Methods, 2018, vol. 1, no. 1, e00007. doi 10.18097/ bmcrm00007
Yoshida, T., Oguro, T., and Kuroiwa, Y., Xenobiotica, 1987, vol. 17, no. 8, pp. 957–963.
Taavitsainen, P., Anttila, M., Nyman, L., Karnani, H., Salonen, J.S., and Pelkonen, O., Pharmacol. Toxicol., 2000, vol. 86, pp. 215–221.
Ershov, P.V., Mezentsev, Yu.V., Yablokov, E.O., Kaluzhskiy, L.A., Florinskaya, A.V., Svirid, A.V., Gilep, A.A., Usanov, S.A., Medvedev, A.E., and Ivanov, A.S., Biomed. Khim., 2018, vol. 64, pp. 61–65. doi 10.18097/PBMC20186401061
Hara, A., Endo, S., Matsunaga, T., El-Kabbani, O., Miura, T., Nishinaka, T., and Terada, T., Biochem. Pharmacol., 2017, vol. 138, pp. 185–192.
Huang, W., Ding, L., Huang, Q., Hu, H., Liu, S., Yang, X., Hu, X., Dang, Y., Shen, S., Li, J., Ji, X., Jiang, S., Liu, J.O., and Yu, L., Hepatology, 2010, vol. 52, pp. 703–714.
Panova, N. G., Zemskova, M.A., Axenova, L.N., and Medvedev, A.E., Neurosci. Lett., 1997, vol. 233, pp. 58–60.
Qvit, N., Joshi, A.U., Cunningham, A.D., Ferreira, J.C., and Mochly-Rosen, D., J. Biol. Chem., 2016, vol. 291, pp. 13608–13621.
Huang, J., Hao, L., Xiong, N., Cao, X., Liang, Z., Sun, S., and Wang, T., Brain Res., 2009, vol. 1279, pp. 1–8.
Senatorov, V.V., Charles, V., Reddy, P.H., Tagle, D.A., and Chuang, D.M., Mol. Cell Neurosci., 2003, vol. 22, pp. 285–297.
Buneeva, O.A., Kopylov, A.T., Kapitsa, I.G., Ivanova, E.A., Zgoda, V.G., and Medvedev, A.E., Cells, 2018, vol. 7, 91. doi 10.3390/cells7080091
ACKNOWLEDGMENTS
This work was performed within the framework of the Program for Basic Research of State Academies of Sciences for 2013–2020 and was partially supported by the Russian Foundation for Basic Research (project no. 18-015-00042).
The LC-MS/MS analysis of proteins was performed in the Center for Collective Use “Human Proteome” (Institute of Biomedical Chemistry) supported by the Ministry of Science and Education of the Russian Federation the within the agreement no. 14.621.21.0017 (the unique identifier RFMEFI-62117X0017).
Supplementary materials are available in the electronic version of the paper at pbmc.ibmc.msk.ru.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Сonflict of interests. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Buneeva, O.A., Kopylov, A.T., Zgoda, V.G. et al. The Effect of Deprenyl and Isatin Administration to Mice on the Proteomic Profile of Liver Isatin-Binding Proteins. Biochem. Moscow Suppl. Ser. B 12, 350–355 (2018). https://doi.org/10.1134/S1990750818040108
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750818040108